Flagship Harbor Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-84
Closed -$2K 638
2020
Q3
$2K Hold
84
﹤0.01% 1699
2020
Q2
$2K Sell
84
-3
-3% -$87 ﹤0.01% 1790
2020
Q1
$2K Hold
87
﹤0.01% 1615
2019
Q4
$3K Hold
87
﹤0.01% 1622
2019
Q3
$3K Hold
87
﹤0.01% 1590
2019
Q2
$3K Sell
87
-40
-31% -$1.71K ﹤0.01% 1596
2019
Q1
$5K Buy
127
+78
+159% +$3.49K ﹤0.01% 1475
2018
Q4
$2K Sell
49
-77
-61% -$4.03K ﹤0.01% 1615
2018
Q3
$8K Hold
126
﹤0.01% 1506
2018
Q2
$7K Buy
+126
New +$6.66K ﹤0.01% 1500

Other funds holding AVNS

Flagship Harbor Advisors's AVNS Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 84 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in AVNS in Q2 2018 and held it in 10 quarters. The position peaked at $8K in Q3 2018. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 84 Avanos Medical shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Avanos Medical in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Avanos Medical position peaked at $8K in Q3 2018.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.